A20 protects endothelial cells from TNF-, Fas-, and NK-mediated cell death by inhibiting caspase 8 activation.

A20 is a stress response gene in endothelial cells (ECs). A20 serves a dual cytoprotective function, protecting from tumor necrosis factor (TNF)-mediated apoptosis and inhibiting inflammation via blockade of the transcription factor nuclear factor-kappaB (NF-kappaB). In this study, we evaluated the molecular basis of the cytoprotective function of A20 in EC cultures and questioned whether its protective effect extends beyond TNF to other apoptotic and necrotic stimuli. Our data demonstrate that A20 targets the TNF apoptotic pathway by inhibiting proteolytic cleavage of apical caspases 8 and 2, executioner caspases 3 and 6, Bid cleavage, and release of cytochrome c, thus preserving mitochondrion integrity. A20 also protects from Fas/CD95 and significantly blunts natural killer cell-mediated EC apoptosis by inhibiting caspase 8 activation. In addition to protecting ECs from apoptotic stimuli, A20 safeguards ECs from complement-mediated necrosis. These data demonstrate, for the first time, that the cytoprotective effect of A20 in ECs is not limited to TNF-triggered apoptosis. Rather, A20 affords broad EC protective functions by effectively shutting down cell death pathways initiated by inflammatory and immune offenders.

[1]  E. Haddad,et al.  Caspase dependence of target cell damage induced by cytotoxic lymphocytes. , 1998, Journal of immunology.

[2]  M S Boguski,et al.  The A20 cDNA induced by tumor necrosis factor alpha encodes a novel type of zinc finger protein. , 1990, The Journal of biological chemistry.

[3]  R. Moyer,et al.  Cytotoxic T Lymphocyte-assisted Suicide , 1998, The Journal of Biological Chemistry.

[4]  Junying Yuan,et al.  Cleavage of BID by Caspase 8 Mediates the Mitochondrial Damage in the Fas Pathway of Apoptosis , 1998, Cell.

[5]  V. Dixit,et al.  The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity. , 1992, The Journal of biological chemistry.

[6]  Vishva M. Dixit,et al.  RAIDD is a new 'death' adaptor molecule , 1997, Nature.

[7]  C. Ferran,et al.  A20 Inhibits Cytokine-Induced Apoptosis and Nuclear Factor κB–Dependent Gene Activation in Islets , 1999, The Journal of experimental medicine.

[8]  D. Green,et al.  Granzyme B Short-Circuits the Need for Caspase 8 Activity during Granule-Mediated Cytotoxic T-Lymphocyte Killing by Directly Cleaving Bid , 2000, Molecular and Cellular Biology.

[9]  F. Bach,et al.  Direct activation of porcine endothelial cells by human natural killer cells. , 1996, Transplantation.

[10]  J. Pober,et al.  Interferon-gamma augments CD95(APO-1/Fas) and pro-caspase-8 expression and sensitizes human vascular endothelial cells to CD95-mediated apoptosis. , 2002, The American journal of pathology.

[11]  J. Pober,et al.  Porcine Endothelial Cells, Unlike Human Endothelial Cells, Can Be Killed by Human CTL Via Fas Ligand and Cannot Be Protected by Bcl-21 , 2002, The Journal of Immunology.

[12]  F. Graham,et al.  Adenovirus-based expression vectors and recombinant vaccines. , 1992, Biotechnology.

[13]  G Cantarella,et al.  Recruitment of the IKK signalosome to the p55 TNF receptor: RIP and A20 bind to NEMO (IKKgamma) upon receptor stimulation. , 2000, Immunity.

[14]  A. Karsan,et al.  Evidence that tumor necrosis factor triggers apoptosis in human endothelial cells by interleukin-1-converting enzyme-like protease-dependent and -independent pathways. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[15]  C. Ferran,et al.  A20 inhibits NF-kappaB activation in endothelial cells without sensitizing to tumor necrosis factor-mediated apoptosis. , 1998, Blood.

[16]  Carol D. Laherty,et al.  The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor kappa B. , 1992, The Journal of biological chemistry.

[17]  S. Srinivasula,et al.  Cytochrome c and dATP-Dependent Formation of Apaf-1/Caspase-9 Complex Initiates an Apoptotic Protease Cascade , 1997, Cell.

[18]  C. Ferran,et al.  A20 protects mice from D‐galactosamine/lipopolysaccharide acute toxic lethal hepatitis , 2002, Hepatology.

[19]  R. Beyaert,et al.  Identification of a Novel A20-binding Inhibitor of Nuclear Factor-κB Activation Termed ABIN-2* , 2001, The Journal of Biological Chemistry.

[20]  R. Contreras,et al.  The zinc finger protein A20 interacts with a novel anti-apoptotic protein which is cleaved by specific caspases , 1999, Oncogene.

[21]  R. Contreras,et al.  The Zinc Finger Protein A20 Inhibits TNF-induced NF-κB–dependent Gene Expression by Interfering with an RIP- or TRAF2-mediated Transactivation Signal and Directly Binds to a Novel NF-κB–inhibiting Protein ABIN , 1999, The Journal of cell biology.

[22]  C. Taylor,et al.  Age-dependent injury in human umbilical vein endothelial cells: relationship to apoptosis and correlation with a lack of A20 expression. , 1995, Laboratory investigation; a journal of technical methods and pathology.

[23]  Mark J. Smyth,et al.  Functional significance of the perforin/granzyme cell death pathway , 2002, Nature Reviews Immunology.

[24]  M. Tewari,et al.  Activation of the B-cell Surface Receptor CD40 Induces A20, a Novel Zinc Finger Protein That Inhibits Apoptosis (*) , 1995, The Journal of Biological Chemistry.

[25]  M. van den Broek,et al.  Effector pathways of natural killer cells. , 1998, Current topics in microbiology and immunology.

[26]  G. Natoli,et al.  Nuclear Factor kB-independent Cytoprotective Pathways Originating at Tumor Necrosis Factor Receptor-associated Factor 2* , 1998, The Journal of Biological Chemistry.

[27]  T. Defrance,et al.  Mitochondria connects the antigen receptor to effector caspases during B cell receptor-induced apoptosis in normal human B cells. , 1999, Journal of immunology.

[28]  A. Porter,et al.  Nuclear c-Myc plays an important role in the cytotoxicity of tumor necrosis factor alpha in tumor cells , 1994, Molecular and cellular biology.

[29]  Ultrastructural studies of complement mediated cell death: a biological reaction model to plasma membrane injury , 1994 .

[30]  M. Jäättelä,et al.  A20 zinc finger protein inhibits TNF and IL-1 signaling. , 1996, Journal of immunology.

[31]  D. Goeddel,et al.  FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. , 1998, Science.

[32]  David Wallach,et al.  Involvement of MACH, a Novel MORT1/FADD-Interacting Protease, in Fas/APO-1- and TNF Receptor–Induced Cell Death , 1996, Cell.

[33]  Hong-Bing Shu,et al.  TRADD–TRAF2 and TRADD–FADD Interactions Define Two Distinct TNF Receptor 1 Signal Transduction Pathways , 1996, Cell.

[34]  Carol D. Laherty,et al.  Human T cell leukemia virus type I Tax and phorbol 12-myristate 13-acetate induce expression of the A20 zinc finger protein by distinct mechanisms involving nuclear factor kappa B. , 1993, The Journal of biological chemistry.

[35]  H. Engelmann,et al.  CD40 induces resistance to TNF‐mediated apoptosis in a fibroblast cell line , 1998, European Journal of Immunology.

[36]  Xiaodong Wang,et al.  Bid, a Bcl2 Interacting Protein, Mediates Cytochrome c Release from Mitochondria in Response to Activation of Cell Surface Death Receptors , 1998, Cell.

[37]  G. Núñez,et al.  Role of cytochrome c and dATP/ATP hydrolysis in Apaf‐1‐mediated caspase‐9 activation and apoptosis , 1999, The EMBO journal.

[38]  Arul M. Chinnaiyan,et al.  FADD, a novel death domain-containing protein, interacts with the death domain of fas and initiates apoptosis , 1995, Cell.

[39]  M. Jäättelä,et al.  A20 zinc finger protein inhibits TNF-induced apoptosis and stress response early in the signaling cascades and independently of binding to TRAF2 or 14-3-3 proteins , 2001, Cell Death and Differentiation.

[40]  L. Filgueira,et al.  Xenogeneic human NK cytotoxicity against porcine endothelial cells is perforin/granzyme B dependent and not inhibited by Bcl‐2 overexpression , 2002, Xenotransplantation.

[41]  G. de Saint Basile,et al.  Perforin: more than just an effector molecule. , 2000, Immunology today.

[42]  M. S. Williams,et al.  Do CTL kill target cells by inducing apoptosis? , 1997, Seminars in immunology.

[43]  D. Goeddel,et al.  The tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-kappaB activation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[44]  R. Beyaert,et al.  Functional redundancy of the zinc fingers of A20 for inhibition of NF‐κB activation and protein–protein interactions , 2001, FEBS letters.

[45]  P. Krammer,et al.  CD95's deadly mission in the immune system , 2000, Nature.

[46]  Ximena Opitz-Araya,et al.  Requirement for Caspase-2 in Stress-Induced Apoptosis Before Mitochondrial Permeabilization , 2002, Science.

[47]  A. Wyllie,et al.  Apoptosis: A Basic Biological Phenomenon with Wide-ranging Implications in Tissue Kinetics , 1972, British Journal of Cancer.

[48]  M. Peter,et al.  Two CD95 (APO‐1/Fas) signaling pathways , 1998, The EMBO journal.

[49]  Junying Yuan,et al.  Activation of Caspase-2 in Apoptosis* , 1997, The Journal of Biological Chemistry.

[50]  F. Graham,et al.  A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5. , 1988, Virology.

[51]  C. Ferran,et al.  A20 Blocks Endothelial Cell Activation through a NF-κB-dependent Mechanism* , 1996, The Journal of Biological Chemistry.

[52]  S. Korsmeyer,et al.  Caspase Cleaved BID Targets Mitochondria and Is Required for Cytochrome c Release, while BCL-XL Prevents This Release but Not Tumor Necrosis Factor-R1/Fas Death* , 1999, The Journal of Biological Chemistry.

[53]  A. Ting,et al.  A20 Inhibits Tumor Necrosis Factor (TNF) Alpha-Induced Apoptosis by Disrupting Recruitment of TRADD and RIP to the TNF Receptor 1 Complex in Jurkat T Cells , 2002, Molecular and Cellular Biology.

[54]  Matthias Mann,et al.  FLICE, A Novel FADD-Homologous ICE/CED-3–like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling Complex , 1996, Cell.

[55]  S. Srinivasula,et al.  CRADD, a novel human apoptotic adaptor molecule for caspase-2, and FasL/tumor necrosis factor receptor-interacting protein RIP. , 1997, Cancer research.

[56]  M. Jäättelä,et al.  TNF-induced mitochondrial changes and activation of apoptotic proteases are inhibited by A20. , 1998, Free radical biology & medicine.

[57]  G. Kroemer,et al.  The mitochondrial death/life regulator in apoptosis and necrosis. , 1998, Annual review of physiology.

[58]  Emad S. Alnemri,et al.  Ordering the Cytochrome c–initiated Caspase Cascade: Hierarchical Activation of Caspases-2, -3, -6, -7, -8, and -10 in a Caspase-9–dependent Manner , 1999, The Journal of cell biology.

[59]  C. Ferran,et al.  Protective genes expressed in endothelial cells: a regulatory response to injury. , 1997, Immunology today.

[60]  J. Platt,et al.  Transient perturbation of endothelial integrity induced by natural antibodies and complement , 1995, The Journal of experimental medicine.

[61]  R. Beyaert,et al.  A20 and A20-binding proteins as cellular inhibitors of nuclear factor-kappa B-dependent gene expression and apoptosis. , 2000, Biochemical pharmacology.

[62]  R. Beyaert,et al.  The cytokine‐inducible zinc finger protein A20 inhibits IL‐1‐induced NF‐κB activation at the level of TRAF6 , 1999, FEBS letters.

[63]  W. Fiers,et al.  Inhibition of tumor necrosis factor-induced necrotic cell death by the zinc finger protein A20. , 1999, Anticancer research.